Daniel J. Hicklin
2023
In 2023, Daniel J. Hicklin earned a total compensation of $1.4M as President and Chief Executive Officer at Werewolf Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Bonus | $332,561 |
|---|---|
| Option Awards | $438,640 |
| Salary | $583,440 |
| Other | $12,263 |
| Total | $1,366,904 |
Hicklin received $583.4K in salary, accounting for 43% of the total pay in 2023.
Hicklin also received $332.6K in bonus, $438.6K in option awards and $12.3K in other compensation.
Rankings
In 2023, Daniel J. Hicklin's compensation ranked 877th out of 3,006 executives tracked by ExecPay. In other words, Hicklin earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 877 out of 3,006 | 71st |
Division Manufacturing | 513 out of 1,650 | 69th |
Major group Chemicals And Allied Products | 350 out of 918 | 62nd |
Industry group Drugs | 340 out of 881 | 61st |
Industry Pharmaceutical Preparations | 230 out of 637 | 64th |
Source: SEC filing on April 12, 2024.
Hicklin's colleagues
We found two more compensation records of executives who worked with Daniel J. Hicklin at Werewolf Therapeutics in 2023.